Login / Signup

Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Qaid Ahmed ShageraGi Jeong CheonYoungil KohMin Young YooKeon Wook KangDong Soo LeeE Edmund KimSung-Soo YoonJune-Key Chung
Published in: European journal of nuclear medicine and molecular imaging (2019)
Pretreatment TMTV was an independent predictor of survival in patients with DLBCL. Importantly, TMTV had an additive prognostic value in patients with a high-risk NCCN-IPI. Thus, the combination of baseline TMTV with NCCN-IPI may improve the prognostication and may be helpful guide the decision for intensive therapy and clinical trials, especially in DLBCL patients with a high-risk NCCN-IPI.
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • clinical trial
  • mesenchymal stem cells
  • bone marrow
  • cell therapy
  • open label
  • smoking cessation
  • replacement therapy